Resources - critical mass assembly

• Experience and infrastructure (in terms of expert staff and advanced facilities) developed over the last decade(s) as a result of European and National projects.
• Currently running projects on receptor - targeted radiopharmaceuticals (EMC_BioSynthema Collaboration Agreement) and newly (within 2013) approved for funding projects (TranScan, ARISTEIA II) on translational research, therapeutic radioligands in oncology.
• Intense service provision to public and private entities in the fields of Radiopharmaceuticals QC and radioisotope/radiopharmaceutical distribution throughout Greece.
• Provision of services related to Radiation Protection of man and environment to a variety of authorities and stakeholders (issuing of certificates).
• Support by GAEC and the government to equip and sustain a National Point for radioactive waste management.